Bhutan vs Cote d'Ivoire: Antimicrobial resistance or decreased susceptibiity (DS/R) to
Bhutan
0
in 2020
Cote d'Ivoire
0
in 2020
Bhutan rank
43rd
Cote d'Ivoire rank
43rd
Antimicrobial resistance or decreased susceptibiity (DS/R) to over time
- Bhutan
- Cote d'Ivoire
How they compare
Bhutan currently reports 0 against 0 in Cote d'Ivoire, a difference of 0.
Across all 7 years both countries report, Cote d'Ivoire has been ahead every year.
Bhutan ranks 43rd and Cote d'Ivoire ranks 43rd of 54 countries.
Cote d'Ivoire has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bhutan | Cote d'Ivoire | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.15 | 7.61 | 6.46 | Cote d'Ivoire |
| 2020s | 0 | 0 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antimicrobial resistance or decreased susceptibiity (ds/r) to, Bhutan or Cote d'Ivoire?
- Bhutan, at 0 against 0 in Cote d'Ivoire as of 2020.
- What is the difference in antimicrobial resistance or decreased susceptibiity (ds/r) to between Bhutan and Cote d'Ivoire?
- 0, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and Cote d'Ivoire?
- 7 years are reported by both, from 2013 to 2020.
- How do Bhutan and Cote d'Ivoire rank globally for antimicrobial resistance or decreased susceptibiity (ds/r) to?
- Bhutan ranks 43rd and Cote d'Ivoire ranks 43rd of 54 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion). Statizoid refreshes it automatically from the source and publishes the full history for both places.